Elisabeth Svanberg

Board member since 2022

Nationality: Swedish

Born: 1961

Independent

Board committees, LEO Pharma

Member of the Innovation Committee and the Remuneration and Nomination Committee.

Positions and management duties

Board member of Egetis Therapeutics AB, Galapagos NV (RemCo Chair) and EPICS Therapeutics (Chair).

Career

Former Chief Medical Officer at Kuste Biopharma and Chief Development Officer at Ixaltis SA. Previous executive roles at Janssen Pharmaceuticals (J&J), Bristol-Myers Squibb and Serono International.

Special competencies

Extensive executive and board experience in global pharmaceuticals and biotech as well as extensive experience of interacting with health authorities (U.S. and EU). Led clinical development programs, late-stage product launches and medical affairs projects at Janssen, Bristol-Myers Squibb and Serono. Advanced business development, portfolio strategy and clinical development at Ixaltis, Kuste Biopharma and in current board roles